RM53 RM53 Pill - brown capsule/oblong, 14mm
Pill with imprint RM53 RM53 is Brown, Capsule/Oblong and has been identified as Sunitinib Malate 12.5 mg. It is supplied by Sun Pharmaceutical Industries Inc.
Sunitinib is used in the treatment of Renal Cell Carcinoma; Pancreatic Cancer; Gastrointestinal Stromal Tumor and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RM53 RM53
Sunitinib Malate
- Imprint
- RM53 RM53
- Strength
- 12.5 mg
- Color
- Brown
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceutical Industries Inc.
- National Drug Code (NDC)
- 63304-0091
- Inactive Ingredients
-
croscarmellose sodium,
magnesium stearate,
mannitol,
povidone k30,
ferric oxide red,
titanium dioxide,
potassium hydroxide,
shellac,
gelatin
Note: Inactive ingredients may vary.
More about sunitinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (35)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
